17alpha-ethynylestradiol multiple interactions ISO Tfap2c (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TFAP2C mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO TFAP2C (Homo sapiens) 6480464 Estradiol affects the expression of TFAP2C mRNA CTD PMID:21826169 17beta-estradiol multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of TFAP2C mRNA CTD PMID:30165855 17beta-estradiol increases activity ISO TFAP2C (Homo sapiens) 6480464 Estradiol results in increased activity of TFAP2C protein CTD PMID:27592001 17beta-estradiol increases expression ISO TFAP2C (Homo sapiens) 6480464 Estradiol results in increased expression of TFAP2C mRNA CTD PMID:26865669 and PMID:28711546 17beta-estradiol increases expression ISO Tfap2c (Mus musculus) 6480464 Estradiol results in increased expression of TFAP2C mRNA CTD PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Tfap2c (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Tfap2c (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Tfap2c (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of TFAP2C mRNA CTD PMID:17035482 and PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TFAP2C mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Tfap2c (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA CTD PMID:14708085 and PMID:16962184 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Tfap2c (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TFAP2C mRNA and SRC protein promotes the reaction [Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA] CTD PMID:14708085 and PMID:17942748 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO TFAP2C (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 4,4'-sulfonyldiphenol decreases methylation ISO Tfap2c (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of TFAP2C exon CTD PMID:33297965 5-aza-2'-deoxycytidine increases expression ISO TFAP2C (Homo sapiens) 6480464 Decitabine results in increased expression of TFAP2C mRNA CTD PMID:16367923 5-aza-2'-deoxycytidine affects expression ISO TFAP2C (Homo sapiens) 6480464 Decitabine affects the expression of TFAP2C mRNA CTD PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [Decitabine co-treated with TFAP2C protein] results in increased expression of ESR1 mRNA more ... CTD PMID:19458056 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of TFAP2C mRNA CTD PMID:33150595 and PMID:36843608 6-propyl-2-thiouracil increases methylation EXP 6480464 Propylthiouracil results in increased methylation of TFAP2C promoter CTD PMID:33150595 aflatoxin B1 increases methylation ISO TFAP2C (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of TFAP2C promoter CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO TFAP2C (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of TFAP2C exon CTD PMID:30157460 amiodarone increases expression ISO TFAP2C (Homo sapiens) 6480464 Amiodarone results in increased expression of TFAP2C mRNA CTD PMID:19774075 arsenite(3-) increases methylation ISO TFAP2C (Homo sapiens) 6480464 arsenite results in increased methylation of TFAP2C promoter CTD PMID:23974009 arsenite(3-) multiple interactions ISO TFAP2C (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to TFAP2C mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO TFAP2C (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of TFAP2C mRNA CTD PMID:15761015 belinostat increases expression ISO TFAP2C (Homo sapiens) 6480464 belinostat results in increased expression of TFAP2C mRNA CTD PMID:26272509 belinostat multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 benzo[a]pyrene increases expression ISO Tfap2c (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of TFAP2C mRNA CTD PMID:23735875 benzo[a]pyrene affects methylation ISO TFAP2C (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of TFAP2C exon and Benzo(a)pyrene affects the methylation of TFAP2C promoter CTD PMID:27901495 and PMID:30157460 benzo[e]pyrene increases methylation ISO TFAP2C (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of TFAP2C exon CTD PMID:30157460 bisphenol A affects expression ISO TFAP2C (Homo sapiens) 6480464 bisphenol A affects the expression of TFAP2C mRNA CTD PMID:21826169 bisphenol A decreases expression ISO TFAP2C (Homo sapiens) 6480464 bisphenol A results in decreased expression of TFAP2C mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TFAP2C mRNA CTD PMID:25181051 carbamazepine affects expression ISO TFAP2C (Homo sapiens) 6480464 Carbamazepine affects the expression of TFAP2C mRNA CTD PMID:25979313 carmustine affects response to substance ISO TFAP2C (Homo sapiens) 6480464 TFAP2C mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chromium atom increases expression ISO TFAP2C (Homo sapiens) 6480464 Chromium results in increased expression of TFAP2C mRNA CTD PMID:21437242 cisplatin affects expression ISO TFAP2C (Homo sapiens) 6480464 Cisplatin affects the expression of TFAP2C mRNA CTD PMID:23300844 clofibrate increases expression ISO Tfap2c (Mus musculus) 6480464 Clofibrate results in increased expression of TFAP2C mRNA CTD PMID:17585979 clomiphene decreases expression ISO TFAP2C (Homo sapiens) 6480464 Clomiphene results in decreased expression of TFAP2C mRNA CTD PMID:26865669 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of TFAP2C mRNA and Copper results in increased expression of TFAP2C mRNA CTD PMID:26033743 and PMID:30556269 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of TFAP2C mRNA and Copper results in increased expression of TFAP2C mRNA CTD PMID:26033743 and PMID:30556269 coumestrol multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO TFAP2C (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of TFAP2C mRNA CTD PMID:18687144 crocidolite asbestos decreases expression ISO TFAP2C (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of TFAP2C mRNA CTD PMID:29523930 crocidolite asbestos decreases expression ISO Tfap2c (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of TFAP2C mRNA CTD PMID:19446018 cylindrospermopsin increases expression ISO TFAP2C (Homo sapiens) 6480464 cylindrospermopsin results in increased expression of TFAP2C mRNA CTD PMID:24921660 diarsenic trioxide decreases expression ISO TFAP2C (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of TFAP2C mRNA CTD PMID:15761015 diethylstilbestrol increases expression ISO TFAP2C (Homo sapiens) 6480464 Diethylstilbestrol results in increased expression of TFAP2C mRNA CTD PMID:26865669 dorsomorphin multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of TFAP2C mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA CTD PMID:19167446 entinostat increases expression ISO TFAP2C (Homo sapiens) 6480464 entinostat results in increased expression of TFAP2C mRNA CTD PMID:26272509 and PMID:27188386 entinostat multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 estrone increases expression ISO TFAP2C (Homo sapiens) 6480464 Estrone results in increased expression of TFAP2C mRNA CTD PMID:26865669 flusilazole affects expression ISO Tfap2c (Mus musculus) 6480464 flusilazole affects the expression of TFAP2C mRNA CTD PMID:21195148 fonofos increases methylation ISO TFAP2C (Homo sapiens) 6480464 Fonofos results in increased methylation of TFAP2C promoter CTD PMID:22847954 fulvestrant decreases expression ISO TFAP2C (Homo sapiens) 6480464 fulvestrant results in decreased expression of TFAP2C mRNA CTD PMID:26865669 genistein increases expression EXP 6480464 Genistein results in increased expression of TFAP2C mRNA CTD PMID:23160963 genistein increases expression ISO TFAP2C (Homo sapiens) 6480464 Genistein results in increased expression of TFAP2C mRNA CTD PMID:26865669 hemin decreases expression EXP 6480464 Hemin results in decreased expression of TFAP2C mRNA CTD PMID:20016031 hexaconazole affects expression ISO Tfap2c (Mus musculus) 6480464 hexaconazole affects the expression of TFAP2C mRNA CTD PMID:21195148 hexadecanoic acid increases phosphorylation ISO TFAP2C (Homo sapiens) 6480464 Palmitic Acid results in increased phosphorylation of TFAP2C protein CTD PMID:28073184 hexestrol increases expression ISO TFAP2C (Homo sapiens) 6480464 Hexestrol results in increased expression of TFAP2C mRNA CTD PMID:26865669 hydrogen peroxide affects expression ISO TFAP2C (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of TFAP2C mRNA CTD PMID:20044591 Indeno[1,2,3-cd]pyrene decreases expression ISO TFAP2C (Homo sapiens) 6480464 indeno(1 more ... CTD PMID:32251684 menadione increases expression ISO Tfap2c (Mus musculus) 6480464 Vitamin K 3 results in increased expression of TFAP2C mRNA CTD PMID:25270620 mercury dibromide multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 mestranol increases expression ISO TFAP2C (Homo sapiens) 6480464 Mestranol results in increased expression of TFAP2C mRNA CTD PMID:26865669 methapyrilene increases methylation ISO TFAP2C (Homo sapiens) 6480464 Methapyrilene results in increased methylation of TFAP2C exon CTD PMID:30157460 methylisothiazolinone increases expression ISO TFAP2C (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of TFAP2C mRNA CTD PMID:31629900 methylmercury chloride decreases expression ISO TFAP2C (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of TFAP2C mRNA CTD PMID:23179753 and PMID:28001369 methylmercury chloride multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO TFAP2C (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of TFAP2C mRNA CTD PMID:26272509 nickel sulfate increases expression ISO TFAP2C (Homo sapiens) 6480464 nickel sulfate results in increased expression of TFAP2C mRNA CTD PMID:22714537 Octicizer decreases expression ISO Tfap2c (Mus musculus) 6480464 2-ethylhexyldiphenylphosphate results in decreased expression of TFAP2C protein CTD PMID:35503735 paclitaxel decreases expression ISO TFAP2C (Homo sapiens) 6480464 Paclitaxel results in decreased expression of TFAP2C mRNA CTD PMID:19682730 panobinostat multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 panobinostat increases expression ISO TFAP2C (Homo sapiens) 6480464 panobinostat results in increased expression of TFAP2C mRNA CTD PMID:26272509 paracetamol decreases expression ISO TFAP2C (Homo sapiens) 6480464 Acetaminophen results in decreased expression of TFAP2C mRNA CTD PMID:29665328 parathion increases methylation ISO TFAP2C (Homo sapiens) 6480464 Parathion results in increased methylation of TFAP2C promoter CTD PMID:22847954 PCB138 multiple interactions ISO Tfap2c (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 picene decreases expression ISO TFAP2C (Homo sapiens) 6480464 picene results in decreased expression of TFAP2C mRNA CTD PMID:32251684 potassium chromate increases expression ISO TFAP2C (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of TFAP2C mRNA CTD PMID:22714537 progesterone decreases expression ISO Tfap2c (Mus musculus) 6480464 Progesterone results in decreased expression of TFAP2C mRNA CTD PMID:22238285 raloxifene decreases expression ISO TFAP2C (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased expression of TFAP2C mRNA CTD PMID:26865669 resveratrol multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of TFAP2C mRNA and Resveratrol results in increased localization of and results in increased activity of TFAP2C protein CTD PMID:16488535 and PMID:23557933 SB 431542 multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO TFAP2C (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of TFAP2C mRNA CTD PMID:25351596 sodium arsenite decreases expression ISO Tfap2c (Mus musculus) 6480464 sodium arsenite results in decreased expression of TFAP2C mRNA CTD PMID:36209798 temozolomide affects response to substance ISO TFAP2C (Homo sapiens) 6480464 TFAP2C mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO TFAP2C (Homo sapiens) 6480464 Temozolomide results in increased expression of TFAP2C mRNA CTD PMID:31758290 terbufos increases methylation ISO TFAP2C (Homo sapiens) 6480464 terbufos results in increased methylation of TFAP2C promoter CTD PMID:22847954 triadimefon affects expression ISO Tfap2c (Mus musculus) 6480464 triadimefon affects the expression of TFAP2C mRNA CTD PMID:21195148 trichostatin A multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [Decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein binds to ESR1 promoter] more ... CTD PMID:19458056 and PMID:27188386 trichostatin A increases expression ISO TFAP2C (Homo sapiens) 6480464 trichostatin A results in increased expression of TFAP2C mRNA CTD PMID:24935251 and PMID:26272509 valproic acid affects expression ISO TFAP2C (Homo sapiens) 6480464 Valproic Acid affects the expression of TFAP2C mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of TFAP2C mRNA CTD PMID:33150595 valproic acid multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 valproic acid increases expression ISO TFAP2C (Homo sapiens) 6480464 Valproic Acid results in increased expression of TFAP2C mRNA CTD PMID:23179753 more ... vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of TFAP2C mRNA CTD PMID:23034163 vorinostat increases expression ISO TFAP2C (Homo sapiens) 6480464 vorinostat results in increased expression of TFAP2C mRNA CTD PMID:26272509 vorinostat multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2C mRNA CTD PMID:27188386 zinc atom multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TFAP2C mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO TFAP2C (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TFAP2C mRNA CTD PMID:18593933